Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal peptide delivery.

H E Bodde1, J C Verhoef, M Ponec

  • 1Center for Bio-Pharmaceutical Sciences, Leiden, The Netherlands.

Biochemical Society Transactions
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of human back versus arm skin region for its suitability to test weak irritants.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

The use of human keratinocytes and human skin models for predicting skin irritation.

Alternatives to laboratory animals : ATLA·2014
Same author

The lipid organisation of the skin barrier: liquid and crystalline domains coexist in lamellar phases.

Journal of biological physics·2013
Same author

Human skin equivalents are an excellent tool to study the effect of moisturizers on the water distribution in the stratum corneum.

International journal of cosmetic science·2012
Same author

Reconstruction of human epidermis on de-epidermized dermis: Expression of differentiation-specific protein markers and lipid composition.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Use of human skin cell cultures for the estimation of potential skin irritants.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

Transdermal delivery of peptide drugs like des-enkephalin-gamma-endorphin shows potential. Enhancing peptide flux, possibly via iontophoresis, is key to improving transdermal bioavailability, as intra-epidermal degradation is minimal.

Area of Science:

  • Pharmacology
  • Drug Delivery
  • Dermatology

Background:

  • Transdermal drug delivery offers advantages in pharmacotherapeutics and patient compliance for peptide drugs.
  • Peptide drugs face challenges in transdermal delivery due to hydrophilicity and high molecular mass.
  • Iontophoresis has shown promise in achieving effective in vivo transdermal dosing for peptides.

Purpose of the Study:

  • To investigate the transepidermal permeation of the dodecapeptide, des-enkephalin-gamma-endorphin, in vitro.
  • To study the in vitro intra(epi-)dermal biotransformation of des-enkephalin-gamma-endorphin.
  • To assess methods for enhancing the transdermal delivery of this peptide.

Main Methods:

  • In vitro study of transepidermal permeation through human stratum corneum.

Related Experiment Videos

  • In vitro assessment of peptide biotransformation within epidermal and dermal layers.
  • Evaluation of skin lipid fluidizers to enhance peptide flux.
  • Main Results:

    • Measurable, albeit small, peptide fluxes were observed through human stratum corneum in vitro.
    • Skin lipid fluidizers demonstrated an ability to enhance these peptide fluxes.
    • The peptide exhibited a surprisingly long half-life in both epidermis and dermis compared to human plasma.

    Conclusions:

    • Enhancing transdermal flux, potentially using iontophoresis, is the primary strategy for improving peptide bioavailability.
    • Intra(epi-)dermal degradation is a minor limiting factor in the transdermal delivery of this dodecapeptide.
    • Transdermal delivery of des-enkephalin-gamma-endorphin is feasible, with flux enhancement being the main challenge.